GNH USA

Europe — EMA

Orlistat Ratiopharm

Orlistat, the active ingredient in Orlistat Ratiopharm, is a lipase inhibitor presented as a oral tablet for weight management in adults with overweight or obesity.

Request sourcing

1
Pack/s

What is Orlistat?

Orlistat, the active ingredient in Orlistat Ratiopharm, is a lipase inhibitor presented as a oral tablet for weight management in adults with overweight or obesity. It helps reduce the amount of fat absorbed from the diet.

GNH USA supplies Orlistat Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Orlistat used for?

Orlistat Ratiopharm acts on the gastrointestinal fat‑absorption pathway and is indicated for: - Overweight and obesity in adults : Provides a calorie reduction by decreasing dietary fat absorption to support weight‑loss efforts . - Weight maintenance after weight loss : Helps maint ‑   . -   t  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Orlistat
Route
Oral Use
Manufacturer
Ratiopharm Gmbh
Origin
EU

Related products